Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
This study is ongoing, but not recruiting participants.
Study NCT00004403.   Last updated on June 23, 2005.
Information provided by FDA Office of Orphan Products Development
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
Cysticercosis
Additional conditions recognized in this trial
Neurocysticercosis
Taeniasis
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Central Nervous System Helminthiasis
Central Nervous System Infections
Central Nervous System Parasitic Infections
Cestode Infections
Helminthiasis
Nervous System Diseases
Parasitic Diseases
Interventions listed in this trial
albendazole
dexamethasone
phenytoin
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anti-Inflammatory Agents
Anticestodal Agents
Antiemetics
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
FDA Office of Orphan Products Development
Johns Hopkins University


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services